A systematic review of existing quality measures for the emergency care of acute ischemic stroke has revealed that only 3 measures meet all of the American College of Cardiology (ACC)/American Heart Association (AHA) evaluation criteria.
Philadelphia, PA—Molecular subtyping and classification of patients for the selection of appropriate treatment and prognosis can now be used in routine clinical care in neurology, according to Teri Manolio, MD, PhD, Director, Division of Genomic Medicine, National Human Genome Research Institute, Rockville, MD, at the 2014 American Academy of Neurology meeting.
Results of the largest study to evaluate the link between cognition and cortical thinning using 3T magnetic resonance imaging (MRI) show cortical thinning in patients with early-stage Parkinson’s disease (PD) that is associated with mild cognitive impairment (MCI) as reflected by lower cognitive function scores. This finding could lead to earlier diagnosis and treatment of PD, the researchers note.
When administered early, intravenous tissue plasminogen activator (tPA), an enzyme that helps dissolve clots, reduces long-term disability in patients with stroke.
The often-prescribed antidepressant citalopram (Celexa), a selective serotonin reuptake inhibitor (SSRI), appears to reduce the formation of amyloid plaques that are associated with Alzheimer’s disease, according to new research in mice and a small cohort of healthy individuals.
Stroke mortality has seen a decline in recent years; however, trends in the incidence of intracerebral hemorrhage (ICH) remain unclear.
Philadelphia, PA—Two investigational monoclonal antibodies against the calcitonin gene-related peptide (CGRP) proved safe and effective at preventing migraine in a pair of phase 2, placebo-­controlled, proof-of-concept trials, researchers reported at the 2014 American Academy of Neurology meeting.
Multiple sclerosis (MS), a chronic inflammatory disease, is one of the leading causes of neurologic disability in young adults.
Philadelphia, PA—A breath-powered intranasal powder form of sumatriptan produces fast and sustained relief of migraine, according to the results of a phase 3, placebo-controlled trial presented at the 2014 American Academy of Neurology meeting.
Philadelphia, PA—Genomic sequenc­ing is starting to yield progress in unraveling the genetics of select forms of epilepsy, with some immediate clinical implications, said David B. Goldstein, PhD, Professor of Molecular Genetics, Microbiology, and Biology, and Director of the Center for Human Genome Variation, Duke University, Durham, NC, at the 2014 meeting of the American Academy of Neurology.
Page 1 of 3
Results 1 - 10 of 22
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology